吲哚菁绿清除试验及肝脏有效血流量评估慢性肝炎患者肝脏储备功能的意义

秦华; 王文政; 王占兰

doi:10.3969/j.issn.1001-5256.2014.02.011

吲哚菁绿清除试验及肝脏有效血流量评估慢性肝炎患者肝脏储备功能的意义

DOI: 10.3969/j.issn.1001-5256.2014.02.011

兰州市第二人民医院感染科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 595
- HTML全文浏览量: 31
- PDF下载量: 245
- 被引次数: 5
出版历程
- 出版日期: 2014-02-20

Significance of ICGR15 and EHBF in evaluating liver reserve function among patients with chronic hepatitis

摘要

摘要:
目的探讨吲哚菁绿清除试验15 min滞留（ICGR15）、肝脏有效血流量（EHBF）评估慢性肝炎患者肝脏储备功能的临床价值。方法对82例慢性肝炎患者在治疗前行ICG清除试验和EHBF测定,同时检测患者ALT、TBil、Alb、PTA、CHE等指标。分别观察轻、中、重度患者;ALT正常与异常组患者;TBil正常与异常组患者的ICGR15、EHBF两项指标变化。对患者的ICGR15、EHBF进行受试者工作特征曲线分析,探讨ICG清除试验及EHBF对病情预测的价值。计量资料数据以中位数±四分位数间距表示,多组间比较采用Kruskal-Wallis H检验;两组间比较采用Mann-Whitney U检验。结果（1）在轻度与重度、中度与重度患者间ICGR15、EHBF差异均有统计学意义（H值分别为5.0、12.0、25.0、29.0,P<0.05）。（2）在ALT正常与异常组间,ICGR15、EHBF的差异无统计学意义（U值为135.5、146.0,P值为0.089、0.155）。（3）在TBil正常与异常组间,ICGR15、EHBF的差异均有统计学意义（U值为68.0、84.0,P&l...
- 吲哚花青绿(ICG) /
- 肝炎,慢性
Abstract:
Objective To investigate the clinical values of indocyanine green ( ICG) retention rate at 15 min ( ICGR15) and effective hepatic blood flow ( EHBF) in evaluating the liver reserve function among patients with chronic hepatitis. Methods Eighty- two patients with chronic hepatitis were included in the study. ICGR15and EHBF were measured by pulse dye densitometry before treatment, and alanine aminotransferase ( ALT) , total bilirubin ( TBil) , albumin, prothrombin activity, and cholinesterase were also measured. ICGR15and EHBF were monitored among mild, moderate, and severe patients, patients with normal ALT and abnormal ALT, and patients with normal TBil and abnormal TBil. The predictive values of ICGR15and EHBF for patients' conditions were analyzed by the receiver operating characteristic ( ROC) curve. The continuous data were expressed as median ± interquartile range. Comparison between more than two groups was made by Kruskal- Wallis H test; comparison between two groups was made by Mann- Whitney U test. Results ICGR15and EHBF showed significant differences between mild and severe patients and between moderate and severe patients ( H = 5. 0 and 12. 0, P < 0. 05 for both; H = 25. 0 and 29. 0, P < 0. 05 for both) . There were no significant differences in ICGR15and EHBF between the patients with normal ALT and those with abnormal ALT ( U = 135. 5, P = 0. 089; U = 146. 0, P = 0. 155) . ICGR15and EHBF also showed significant differences between the patients with normal TBil and those with abnormal TBil ( U = 68. 0, P < 0. 05; U = 84. 0, P < 0. 05) . The areas under the ROC curve of ICGR15, EHBF, ALT, and TBil were 0. 434, 0. 497, 0. 622, and 0. 521, respectively, in mild patients, 0. 969, 0. 075, 0. 900, and 1. 000, respectively, in moderate patients, and 0. 861, 0. 161, 0. 759, and 0. 950, respectively, in severe patients. Conclusions ICG clearance test is an accurate method for quantitatively assessing the liver reserve function and is helpful for taking timely, effective intervention. This test is of great clinical significance.
- indocyanine green /
- hepatitis, chronic

HTML全文

参考文献(15)

[1]LI GM.Correlation analysis of liver function reserve and hepatic fibrosis in patients with chronic liver disease[J].China Med Herald, 2012, 9 (13) :181-182. (in Chinese) 李广明.慢性肝病肝脏储备功能与肝纤维化的相关性分析[J].中国医药导报, 2012, 9 (13) :181-182.

[2]LI BL, MU Y, JIANG L, et al.Evaluation on hepatic reserve function of patients with hepatocellular carcinoma after partial hepatectomy by Child-Pugh classification with Fibroscan and ICG measurement[J].Chin J Liver Dis:Electron Vers, 2013, 5 (3) :5-8. (in Chinese) 李宝亮, 穆毅, 蒋力, 等.Child-Pugh分级联合ICG与肝瞬时弹性值评估肝部分切除术肝细胞癌患者肝储备功能[J].中国肝脏病杂志:电子版, 2013, 5 (3) :5-8.

[3]Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.The programme of prevention and cure for viral hepatitis[J].Chin J Hepatol, 2000, 8 (6) :324-329. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329.

[4]HASHIMOTO M, WATANABE G.Hepatic parenchymal cell volume and the indocyanine green tolerance test[J].J Surg Res, 2000, 92 (2) :222-227.

[5]MATSUI Y, TU W, KITDAE H, et al.Hepatocyte volume as an indicator of hepatic functional reserve in cirrhotic patients with live tumours[J].J Gastroenterol Hepatol, 1996, 11 (3) :540-548.

[6]SCHEINGRABER S, RICHTER S, IGNA D, et al.Indocyanine green elimination but not bilirubin indicates improvement of graft function during MARS therapy[J].Clin Transplant, 2007, 21 (6) :689-695.

[7] DONG JH, ZHENG SS, CHEN XP, et al.Consensus on evaluation of hepatic functional reserve before hepatectomy (2011 edition) [J].Chin J Digest Surg, 2011, 10 (1) :20-25. (in Chinese) 董家鸿, 郑树森, 陈孝平, 等.肝切除术前肝脏储备功能评估的专家共识 (2011版) [J].中华消化外科杂志, 2011, 10 (1) :20-25.

[8]LI JF, HU YQ, HE SQ.Research progress in evaluation of liver reserve function[J].China Med Herald, 2013, 10 (24) :41-44. (in Chinese) 李江发, 胡虞乾, 何松青.肝脏储备功能评估的研究进展[J].中国医药导报, 2013, 10 (24) :41-44.

[9]YUAN JL, DING YM, WANG B.Clinical value of ICGR15for assessing hepatic resering function in liver cirrhosis patients after pericardil devascularization[J].J Clin Hepatol, 2012, 28 (9) :671-673. (in Chinese) 袁吉林, 丁佑铭, 汪斌.ICGR15在肝硬化断流术前评估肝脏储备功能的应用价值[J].临床肝胆病杂志, 2012, 28 (9) :671-673.

[10]YOSHITAKA I, MANABU M, EIJI M, et al.Clinical applications of ICG Finger Monitor in patients with liver disease[J].Hepatology, 1993, 19 (2) :232-240.

[11]FAYBIK P, HETZ.PLASMA H.Disappearance Rate of Indocyanine Green in Liver Dysfunction[J].Transplantation Proceedings, 2006, 38 (3) :801-802.

[12]HU SL, HU AR, JIANG SW, et al.Evaluation of indocyanine green clearance test for estimation of prognosis in patients with liver failure[J].Chin Prev Med, 2012, 13 (6) :443-446. (in Chinese) 胡守廉, 胡爱荣, 蒋素文, 等.脉冲式色素浓度分析法吲哚菁绿清除试验在肝衰竭患者预后判断中的价值[J].中国预防医学杂志, 2012, 13 (6) :443-446. (in Chinese)

[13]MA CH, CHEN Y, CHEN CW, et al.Prognostic value of indocyanine green and liver reserve function in acute and acute-on-chronic liver failure patients[J].J Clin Hepatol, 2012, 28 (5) :372-375. (in Chinese) 马春华, 陈煜, 陈成伟, 等.吲哚菁绿清除试验对急性/慢加急性肝衰竭患者预后的评价[J].临床肝胆病杂志, 2012, 28 (5) :372-375.

[14] HASHIMOTO M, WATANABE G.Hepatic parenchymal cell volume and the indocyanine green tolerance test[J].J Surg Res, 2000, 92 (2) :222-227.

[15]LI K, FENG XB, LIN H, et al.Clinical significance of pulse dye densitometry in effective hepatic blood flow detection[J].J Third Milit Med Univ, 2009, 31 (23) :2358-2360. (in Chinese) 李昆, 冯晓彬, 林恒, 等.脉动色素浓度测定法检测有效肝脏血流量对肝病患者的临床意义[J].第三军医大学学报, 2009, 31 (23) :2358-2360.

施引文献

期刊类型引用(5)

1.	康志龙，周益民，宋燕州，张昆，苏一男，魏文平，赵新，李志伟. 靶向免疫治疗联合经肝动脉灌注化疗治疗不可切除肝细胞癌的临床效果及转化治疗的影响因素. 中国医学创新. 2025(01): 47-51 . 百度学术
2.	许海明，胡永奎，梁平，钟腾猛，陆炳站. 中晚期肝癌患者经动脉化疗栓塞治疗后短期效果及长期预后的影响因素分析. 大医生. 2025(06): 27-31 . 百度学术
3.	彭林辉，陈涛，徐云修修，王捷，陈捷，李永，黄拼搏，钟国平，陈茜，叶聪婷，陈亚进. mFOLFOX7方案全身化疗联合卡瑞利珠单克隆抗体和阿帕替尼治疗肝细胞癌合并Vp4型门静脉癌栓的疗效. 中华消化外科杂志. 2024(02): 265-271 . 百度学术
4.	李洁，李瑞娟，鲁志兵，曾筱怡. 肝动脉灌注化疗联合程序性死亡受体1抗体及仑伐替尼治疗晚期肝癌合并门静脉癌栓的效果. 中国当代医药. 2024(26): 43-46+51 . 百度学术
5.	黄乾鑫，神斌，肖晋昌，高志康，吕墩涛，李艳，徐浩，张庆桥. 载药微球经导管动脉化疗栓塞术联合肠系膜上动脉灌注化疗治疗肝细胞癌合并门静脉癌栓的效果分析. 临床肝胆病杂志. 2024(12): 2457-2463 . 本站查看